Friday November 27 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Hemangioendothelioma

Below is an extended Hemangioendothelioma patents listing. Click here to return to the Hemangioendothelioma main in depth entry.

Patents :

US Patent No.Title
7413864 Treating cancer using a telomerase vaccine
7470667 Methods of treating cancer using a modified endostatin protein
7473528 Method for the detection of Chagas disease related gene transcripts in blood
7476726 Method of producing and purifying endostatin protein
7482004 Inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumor formation and/or vascular leakage
7482013 Albumin fusion proteins
7485439 Nucleic acids encoding plasminogen fragments and methods of use
7494977 Polypeptides homologous to VEGF and BMP1
7494979 Method for treating congestive heart failure and other disorders
7495089 Therapeutic antiangiogenic endostatin compositions
7507413 Albumin fusion proteins
7468379 Inhibition of osteolytic lesions by SRC kinase inhibitors
7462355 Angiogenesis regulation system
7459531 50 Human secreted proteins
7427605 Inhibitors of ribonucleotide reductase subunit 2 and uses thereof
7429681 Combretastatin analogs with tubulin binding activity
7432303 Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states
7435745 Methods and compositions for inhibition of angiogenesis
7438931 Methods and compositions for the treatment of angiogenic diseases
7442514 Mutants of the factor VII-activating protease and detection methods using specific antibodies
7442778 Modified Fc molecules
7449555 Antibodies of angiogenesis inhibiting domains CD148
7452531 Compositions and methods for tumor-targeted delivery of effector molecules
7456214 Chromene-containing compounds with anti-tubulin and vascular targeting activity
7507414 Albumin fusion proteins
7514079 Antibodies that specifically bind to neurokinin B
7575879 Polypeptides homologous to VEGF and BMP1
7576066 Nucleic acid compositions for stimulating immune responses
7585622 Increasing the proliferative capacity of cells using telomerase reverse transcriptase
7592010 Albumin fusion proteins
7598345 Immunostimulatory compositions and methods
7601355 Compositions and methods for altering immune function
7605138 Nucleic acid compositions for stimulating immune responses
7605156 Methods for the use of inhibitors of cytosolic phospholipase A2
7605235 Anti-tissue factor antibodies and compositions
7605239 Skeletal-targeted radiation to treat bone-associated pathologies
7569553 Nucleic acid compositions for stimulating immune responses
7569384 Albumin fusion proteins
7560438 Genetic inhibition by double-stranded RNA
7517971 Muteins of human telomerase reverse transcriptase lacking telomerase catalytic activity
7521053 Angiopoietin-2 specific binding agents
7521424 Albumin fusion proteins
7524935 Sequences characteristic of hypoxia-regulated gene transcription
7534772 Methods for enhancing antibody-induced cell lysis and treating cancer
7538095 Genetic inhibition by double-stranded RNA
7541160 ELISA for VEGF
7556809 Active antiangiogenic therapy
7557135 Inhibitors of cytosolic phospholipase A.sub.2
7560437 Nucleic acid compositions for eliciting an immune response against telomerase reverse transcriptase
7611700 Protease resistant modified interferon alpha polypeptides

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.